DeepSight Technology announced today that it received FDA 510(k) clearance for its NeedleVue LC1 ultrasound system.

Lifecare today announced positive steps taken toward bringing a continuous glucose monitor (CGM) implant to the European ...

Vicarious Surgical (NYSE:RBOT) shared new details about clinical trial timelines for its surgical robot, leading to potential ...

Phyxiom, developer of a platform aiming to enhance asthma and COPD management, has announced its official launch.

Reprieve Cardiovascular announced today that it closed an oversubscribed Series B financing totaling $61 million.